Exhibit 1
JOINT FILING AGREEMENT
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G with respect to Common Stock of Coronado Biosciences, Inc. is filed on behalf of each of the undersigned and that all subsequent amendments to this statement (including amendments on Schedule 13D) may be filed on behalf of each of the undersigned in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, without the necessity of filing additional joint filing agreements.
| |
|
|
|
Date: February 6, 2015
|
|
|
| |
|
|
|
| |
/s/ Mr. Daryl Katz |
|
| |
Mr. Daryl Katz |
|
| |
|
|
|
| |
|
|
|
| |
DAK CAPITAL INC.
|
|
| |
|
|
|
| |
|
|
|
| |
By: |
/s/ Mr. Daryl Katz |
|
| |
|
Mr. Daryl Katz, President |
|
| |
|
|
|
| |
DAK
INVESTMENTS (US) CORP.
|
|
| |
|
|
|
| |
By: |
/s/ Mr. Daryl Katz |
|
| |
|
Mr. Daryl Katz, President |
|